Women's Health

A survey of sexually active women in the United States revealed that 29% experienced challenges in obtaining either a prescription or a refill for hormonal contraception.

Researchers at Kaiser Permanente Washington conducted a qualitative pilot study to understand the experiences and decision-making women face as they contemplate the use of antinausea medications during pregnancy.

Using a drug that increases GABA synthesis and possibly escalates intraneuronal dopamine in a population that is more likely to have behavior health concerns may prove to be an unsafe option.

Officials with the FDA have approved olaparib (Lynparza, AstraZeneca and MSD) for the maintenance treatment of adult patients with BRCA-mutated advanced ovarian cancer.

Hot flashes are a huge problem across the general population, but even more so in breast cancer survivors.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

According to TherapeuticsMD, Bijuva is the first and only FDA-approved bio-identical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate to severe vasomotor symptoms due to menopause in women with a uterus.

Mylan announced Thursday it has launched Medroxyprogesterone Acetate (MPA) Injectable Suspension USP, 150 mg/mL Single-Dose Vial in the United States for the prevention of pregnancy.

In recognition of the first National Women Pharmacists Day today, October 12, Specialty Pharmacy Times conducted an interview with female pharmacy leaders and a pharmacy student to hear their unique perspectives on the state of the industry, as well as challenges and opportunities in store ownership.

Oct. 12 is the day to honor women pharmacists everywhere.

Women make up 50.8% of the US population, according to the 2010 US Census.

Pregnant women take herbal and natural products (HNPs) as alternatives to prescription medications, but, HNPs have active ingredients and drug interactions that can potentially cause harm to both the mother and her baby.

The vaginal inserts can reduce symptoms such as hot flashes and mood swings.

Some researchers propose that vasomotor symptoms may signal physiologic processes that might be associated with other related systemic health diagnoses.

The effect of chemotherapy on functional status can be critical for older adults, as declining function can inhibit the ability to live independently and perform daily activities.

If it’s not immediately obvious to you what leadership skills female pharmacists share with Apache helicopter pilots, you probably haven’t been working in pharmacy for very long.

The latest recommendation from the United States Preventive Services Task Force said cervical cancer screening depends on a woman’s age and other factors.

The FDA has approved a combined hormonal contraceptive for women that is the first vaginal ring contraceptive that can be used for an entire year.

The FDA has permitted marketing of Natural Cycles, the first mobile medical app that can be used as a method of contraception to prevent pregnancy.

Few young women develop venous thromboembolism, but 2 circumstances increase risk in women of childbearing age: pregnancy, and the use of sex hormones, including oral contraceptives.

Clinicians generally have 2 options for women who develop endometriosis: surgery or medical therapies. The goal is to address active symptoms, prevent recurrence, and control pain.

Survey authors identified an unmet need for clinician engagement regarding financial concerns after breast cancer diagnosis.

The FDA is warning consumers against serious risks of some ‘vaginal rejuvenation’ devices, and a lack of evidence to support their uses for this purpose.

The FDA has approved AbbVie's elagolix (Orilissa) product, a drug specifically developed for women with moderate to severe endometriosis pain.

Data collected from a number of patient safety reporting programs indicate that between 2% and 35% of prescription errors are linked to look alike, sound alike drug name similarities.

In general, infertility is described as an inability to conceive despite having frequent, unprotected intercourse for a year or more.

Officials with the FDA have granted accelerated approval to pembrolizumab (Keytruda, Merck) for 2 new indications, including the treatment of refractory primary mediastinal large B-cell lymphoma (PMBCL), and recurrent metastatic cervical cancer in previously treated patients whose tumors express PD-L1.

TherapeuticsMD announced it has received FDA approval for IMVEXXY (estradiol vaginal inserts) for the treatment of moderate-to-severe dyspareunia.

Health care providers should be aware of how HIV symptoms may affect menopausal women.